‌

US Patent 10912772 Opioid formulations

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Markus Johnsson0

Fredrik Tiberg0

Ian Harwigsson0

Date of Patent

February 9, 2021

0

Patent Application Number

168821860

Date Filed

May 22, 2020

0

Patent Citations

US Patent 10558394 Injectable flowable composition comprising buprenorphine

US Patent 10588859 Topical formulations having enhanced bioavailability

US Patent 10587864 Image processing device and method

0

US Patent 10592168 Injectable flowable composition comprising buprenorphine

US Patent 10022367 Sustained-release buprenorphine solutions

US Patent 10198218 Injectable flowable composition comprising buprenorphine

Patent Primary Examiner

0

Patent abstract

A depot precursor formulation comprising:a) a controlled-release matrix;b) at least oxygen containing organic solvent;c) at least 12% by weigh of at least one active agent selected from buprenorphine and salts thereof, calculated as buprenorphine free base.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10912772 Opioid formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.